How will brepocitinib cream compare with established treatments for mild-to-moderate eczema?

Funding sources: S.J.L. is funded by a National Institute for Health Research (NIHR) Research for Patient Benefit Grant (NIHR201993) to conduct a Cochrane network meta-analysis of topical anti-inflammatory treatments for eczema, and a grant from the NIHR Systematic Review Programme to Cochrane Skin. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Systematic Review Programme, NIHR, National Health Service or Department of Health. The funders were not involved in the manuscript preparation.

Conflicts of interest: S.J.L. has no conflicts of interest. A.D. has received compensation from the British Journal of Dermatology (reviewer and section editor), American Academy of Dermatology (guidelines writer) and National Eczema Association (grant reviewer).